http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109091532-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-537 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-481 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-537 |
| filingDate | 2018-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109091532-B |
| titleOfInvention | Application of Tongguan capsule in preparation of medicine for treating hypertension and heart failure |
| abstract | The invention relates to the field of medicines, in particular to a new application of a Tongguan capsule, and in particular relates to an application of the Tongguan capsule in preparation of a hypertensive heart failure medicine, wherein the main active ingredients of the Tongguan capsule comprise the following raw material medicines in percentage by weight: 40-60% of astragalus membranaceus, 20-50% of salvia miltiorrhiza and 5-25% of leech. Experiments prove that the coronary dredging capsule has good treatment and relief effects on improving ventricular hypertrophy, increasing cardiac contractility, delaying ventricular remodeling and treating and improving hypertensive heart failure, and the treatment effect of the coronary dredging capsule is superior to that of metoprolol; moreover, the capsule has less medicinal flavor, reliable curative effect determination, definite medicinal effect components and less adverse reaction, and can obviously improve the prognosis and the life quality of patients. |
| priorityDate | 2018-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 70.